Amgen Inc (NASDAQ:AMGN)

195.47
Delayed Data
As of Sep 13
 +1.47 / +0.76%
Today’s Change
166.30
Today|||52-Week Range
211.90
+0.41%
Year-to-Date

Today’s Trading

Previous close194.00
Today’s open194.41
Day’s range194.33 - 196.67
Volume2,428,846
Average volume (3 months)3,046,448
Market cap$117.2B
Data as of 3:59pm ET, 09/13/2019

Growth & Valuation

Earnings growth (last year)+368.59%
Earnings growth (this year)-0.70%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)+4.32%
P/E ratio15.5
Price/Sales5.45
Price/Book9.85

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences+0.16+0.24%
ILMNIllumina Inc+3.39+1.14%
BIIBBiogen+4.32+1.86%
EXASExact Sciences Corp-1.98-1.82%
Data as of 4:00pm ET, 09/13/2019

Financials

Next reporting dateOctober 31, 2019
EPS forecast (this quarter)$3.49
Annual revenue (last year)$23.8B
Annual profit (last year)$8.4B
Net profit margin35.32%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Esteban Santos
Corporate headquarters
Thousand Oaks, California

Forecasts